About Southeast Kidney Center
Address: 8537 Bldg A Gulf Freeway, Houston, Harris County, TX, 77017Phone Number: (713) 947-9564
Certification Date: June 04, 1979
Type and Organization: Profit, Fresenius Medical Care
Number of Dialysis Stations: 32
Southeast Kidney Center Location on Map
Service Offers and Quality Reviews
- In-Center Hemodialysis (YES)
- In-Center Peritoneal Dialysis (YES)
- Home Hemodialysis Training (NO)
- SHR: Upper Confidence Limit (95%): 1.6
- SMR: Upper Confidence Limit (95%): 1.35
- SHR: Lower Confidence Limit (5%): 0.55
- SMR: Lower Confidence Limit (5%): 0.84
- Number of patients included in hospitalization summary: 128
- Number of patients included in survival summary: 610
- Standardized hospitalization ratio: 0.92
- Standardized mortality ratio: 1.07
- Percentage of Medicare patients with Hgb< 10 g/dL: 0.03
- Percentage of Medicare patients with Hgb>12 g/dL: 0.02
- Number of dialysis patients with Hgb data: 92
- Percentage of HD patients with URR>=65%: 1
- Percent of Adult HD patients with Kt/V >= 1.2: 0.9
- Percentage of Adult PD PTS with Kt/V >= 1.7: 0.69
- Number of HD patients with URR data: 80
- Number of Adult HD patients with Kt/V data: 111
- Number of Adult HD patient-months with Kt/V data: 895
- Number of Adult PD patients with Kt/V data: 17
- Number of Adult PD patient-months with Kt/V data: 118
- Number of Pediatric HD patients with Kt/V data: 0
- Number of Pediatric HD patient-months with Kt/V data: 0
- Percentage of patients with arteriovenous fistulae in place: 0.53
- Percentage of patients with vascular catheter in use for 90 days or longer: 0.14
- Number of Adult patients included in arterial venous fistula and catheter summaries: 115
- Number of Adult patient-months included in arterial venous fistula and catheter summaries: 929
(Claims Date: 07/01/2011-06/30/2012; SMR Date: 01/01/2008-12/31/2011; SHR Date: 01/01/2011-12/31/2011)
n/a = Data note available or the number of patients is too small to report, please contacts the dialysis facility to discuss this quality measure.
No comments:
Post a Comment